V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003140 | 330001657 | 1.7 | 83.6 | Palliative (P) | null | 2017-05-03 | DOXORUBICIN | null | null | 330012259 | DOXORUBICIN |
| 330003141 | 330006882 | 1.71 | 62.8 | Palliative (P) | 2013-10-16 | 2013-10-23 | CARBOPLATIN + PACLITAXEL | N | N | 330012261 | CARBOPLATIN + PACLITAXEL |
| 330003142 | 330006882 | 1.71 | 91 | Palliative (P) | 2016-11-12 | 2016-12-11 | CARBOPLATIN + PACLITAXEL | N | N | 330012261 | CARBOPLATIN + PACLITAXEL |
| 330003143 | 330001658 | 1.6 | 102 | Palliative (P) | 2015-06-05 | 2015-06-12 | DOXORUBICIN | null | null | 330012269 | DOXORUBICIN |
| 330003144 | 330001658 | 0 | 63 | Curative (C) | 2015-03-12 | 2015-03-03 | Rituximab | 02 | N | 330012269 | RITUXIMAB |
| 330003145 | 330001659 | 1.59 | 75 | Curative (C) | 2015-03-14 | 2015-03-17 | CARBOPLATIN | N | N | 330012271 | CARBOPLATIN |
| 330003146 | 330001659 | 1.66 | 48.7 | Palliative (P) | 2018-07-21 | 2018-08-10 | CARBOPLATIN + PACLITAXEL | Y | null | 330012271 | CARBOPLATIN + PACLITAXEL |
| 330003147 | 330009714 | 1.65 | 95 | Not known (9) | 2012-12-10 | 2013-10-01 | Carboplatin AUC 6 - 10 | N | N | 330012275 | CARBOPLATIN |
| 330003148 | 330009714 | 0.52 | null | Disease modification (D) | 2013-12-09 | 2013-12-09 | Liposomal Doxorubicin (Caelyx) | 2 | null | 330012275 | LIPOSOMAL DOXORUBICIN |
| 330003149 | 330001660 | null | 81.9 | Curative (C) | 2016-04-19 | 2016-04-20 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330012278 | LIPOSOMAL DOXORUBICIN |
| 330003150 | 330001660 | 1.58 | 101.3 | Curative (C) | 2013-05-18 | 2013-05-25 | Carboplatin AUC 2 - 5 | N | Y | 330012278 | CARBOPLATIN |
| 330003151 | 330001660 | 1.57 | 50.5 | null | null | 2015-11-07 | Cisplatin + Doxorubicin | N | N | 330012278 | CISPLATIN + DOXORUBICIN |
| 330003152 | 330001660 | 1.73 | null | Adjuvant (A) | 2013-04-02 | 2013-04-14 | CARBOPLATIN + ETOPOSIDE | 2 | null | 330012278 | CARBOPLATIN + ETOPOSIDE |
| 330003153 | 330001660 | 1.6 | 77.4 | Palliative (P) | 2015-12-20 | 2016-01-06 | Carboplatin + Paclitaxel (weekly) | N | N | 330012278 | CARBOPLATIN + PACLITAXEL |
| 330003154 | 330001660 | 1.7 | 80.5 | Neo-adjuvant (N) | 2013-05-17 | 2013-05-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012278 | CARBOPLATIN + PACLITAXEL |
| 330003155 | 330001660 | 1.47 | 104 | Not known (9) | 2019-01-29 | 2019-01-29 | Carboplatin AUC 2 - 5 | 02 | N | 330012278 | CARBOPLATIN |
| 330003156 | 330001660 | 1.88 | null | Disease modification (D) | 2015-12-05 | 2015-12-26 | Bendamustine+Rituximab (1st Course) | N | N | 330012278 | BENDAMUSTINE + RITUXIMAB |
| 330003157 | 330001660 | 1.77 | 86 | Adjuvant (A) | 2016-11-06 | 2016-11-07 | CARBOPLATIN | 02 | N | 330012278 | CARBOPLATIN |
| 330003158 | 330001660 | 1.7 | 81.8 | Curative (C) | 2016-05-15 | 2016-05-20 | Carboplatin AUC 6 - 10 | 2 | N | 330012278 | CARBOPLATIN |
| 330003159 | 330001660 | 1.79 | 81.1 | Palliative (P) | null | 2017-10-03 | Carboplatin + Etoposide IV 3 day | N | N | 330012278 | CARBOPLATIN + ETOPOSIDE |
| 330003160 | 330001660 | 1.63 | 7 | Not known (9) | 2016-06-27 | 2016-07-11 | Rituximab | 2 | null | 330012278 | RITUXIMAB |
| 330003161 | 330001661 | null | 65.4 | Not known (9) | null | 2014-01-29 | BENDAMUSTINE + RITUXIMAB | N | Y | 330012305 | BENDAMUSTINE + RITUXIMAB |
| 330003162 | 330001661 | null | 58.7 | Curative (C) | 2016-08-25 | 2016-08-25 | CNS GCT II Germinoma - Carbo Etop | N | N | 330012305 | CARBOPLATIN + ETOPOSIDE |
| 330003163 | 330001662 | 1.77 | 94.8 | Palliative (P) | 2015-02-08 | 2015-02-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330012311 | CARBOPLATIN + ETOPOSIDE |
| 330003164 | 330006887 | 1.59 | 61 | Palliative (P) | 2013-10-20 | 2013-10-21 | Doxorubicin 75mg/m2 | N | N | 330012312 | DOXORUBICIN |
| 330003165 | 330006887 | 1.72 | 52.3 | Palliative (P) | 2014-03-12 | 2014-03-29 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330012312 | CARBOPLATIN + PACLITAXEL |
| 330003166 | 330006887 | 1.61 | 87.2 | Palliative (P) | 2015-01-28 | 2015-02-04 | CARBOPLATIN + PACLITAXEL | 01 | N | 330012312 | CARBOPLATIN + PACLITAXEL |
| 330003167 | 330006887 | 1.68 | 87.8 | Curative (C) | 2016-09-03 | 2016-09-10 | CNS GCT II Germinoma - Carbo Etop | 02 | N | 330012312 | CARBOPLATIN + ETOPOSIDE |
| 330003168 | 330001663 | 1.79 | 75 | Not known (9) | 2016-02-01 | 2016-02-04 | Liposomal Doxorubicin (Caelyx) | N | N | 330012321 | LIPOSOMAL DOXORUBICIN |
| 330003169 | 330001664 | 1.77 | 91.9 | Palliative (P) | 2013-04-26 | 2013-05-11 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012324 | CARBOPLATIN + PACLITAXEL |
| 330003170 | 330001665 | 1.72 | 79.5 | null | 2016-05-10 | 2016-05-10 | Doxorubicin 75mg/m2 | Y | N | 330012329 | DOXORUBICIN |
| 330003171 | 330001666 | 1.62 | 79.3 | Neo-adjuvant (N) | 2015-06-20 | 2015-06-24 | Cisplatin + Doxorubicin | N | N | 330012332 | CISPLATIN + DOXORUBICIN |
| 330003173 | 330006888 | 0 | 56 | Adjuvant (A) | 2013-10-21 | 2013-10-21 | Carboplatin + Paclitaxel (weekly) | N | N | 330012339 | CARBOPLATIN + PACLITAXEL |
| 330003174 | 330009717 | 1.55 | 56.9 | Not known (9) | 2013-10-02 | 2013-10-22 | Bendamustine+Rituximab (1st Course) | N | Y | 330012340 | BENDAMUSTINE + RITUXIMAB |
| 330003175 | 330001668 | 1.67 | 56 | Disease modification (D) | 2018-01-26 | 2018-01-26 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 330012345 | BENDAMUSTINE + RITUXIMAB |
| 330003176 | 330001669 | 1.64 | 58.7 | Disease modification (D) | 2014-10-20 | 2014-10-21 | Rituximab | N | N | 330012347 | RITUXIMAB |
| 330003177 | 330001669 | 1.6 | 49.8 | Palliative (P) | 2014-08-31 | 2014-08-31 | Liposomal Doxorubicin (Caelyx) | N | N | 330012347 | LIPOSOMAL DOXORUBICIN |
| 330003178 | 330001669 | 1.8 | 92.6 | Palliative (P) | 2015-09-10 | 2015-09-21 | Cisplatin + Doxorubicin | 2 | null | 330012347 | CISPLATIN + DOXORUBICIN |
| 330003179 | 330001670 | 1.6 | 90 | Palliative (P) | 2014-01-31 | 2014-02-05 | DOXORUBICIN | 01 | N | 330012352 | DOXORUBICIN |
| 330003180 | 330001670 | 1.79 | 63.6 | Not known (9) | 2015-11-04 | 2015-11-18 | BENDAMUSTINE + RITUXIMAB | N | N | 330012352 | BENDAMUSTINE + RITUXIMAB |
| 330003181 | 330001670 | 1.7 | 70 | Palliative (P) | 2013-03-05 | 2013-03-15 | CARBOPLATIN + ETOPOSIDE | N | N | 330012352 | CARBOPLATIN + ETOPOSIDE |
| 330003182 | 330001671 | 1.6 | 64.6 | Neo-adjuvant (N) | 2013-12-02 | 2013-12-02 | Carboplatin + Etoposide IV 3 day | 2 | N | 330012358 | CARBOPLATIN + ETOPOSIDE |
| 330003183 | 330001671 | 1.73 | 89.6 | Not known (9) | 2013-10-22 | 2013-10-29 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330012358 | BENDAMUSTINE + RITUXIMAB |
| 330003184 | 330001671 | 1.81 | 100.3 | Disease modification (D) | 2015-02-27 | 2015-02-27 | Rituximab | N | N | 330012358 | RITUXIMAB |
| 330003185 | 330001672 | 1.53 | 71.5 | Palliative (P) | 2014-03-07 | 2014-03-14 | Rituximab | null | null | 330012370 | RITUXIMAB |
| 330003186 | 330001672 | 1.68 | 85.8 | Adjuvant (A) | 2013-11-30 | 2013-12-02 | Cisplatin + Doxorubicin | N | N | 330012370 | CISPLATIN + DOXORUBICIN |
| 330003187 | 330001673 | 1.75 | 72.5 | Curative (C) | 2017-12-23 | 2017-12-30 | Cisplatin + Doxorubicin | N | N | 330012373 | CISPLATIN + DOXORUBICIN |
| 330003188 | 330001674 | 0.02 | 52 | Disease modification (D) | 2014-10-07 | 2014-10-07 | Rituximab | 2 | null | 330012374 | RITUXIMAB |
| 330003189 | 330001675 | 1.83 | 80.74 | Not known (9) | 2017-02-19 | 2017-02-24 | DOXORUBICIN | N | N | 330012378 | DOXORUBICIN |
| 330003190 | 330001676 | 1.6 | 59 | Palliative (P) | 2017-05-14 | 2017-05-27 | Carboplatin + Etoposide IV 3 day | null | null | 330012379 | CARBOPLATIN + ETOPOSIDE |